BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6291163)

  • 1. [Blood sugar control in diabetics with the insulin pump. Comparison with discontinuous injections].
    Sudre Y; Abadie JC; Marechaud R; Rossi F; Gouet D; Queron B
    Sem Hop; 1982 Sep; 58(32):1801-4. PubMed ID: 6291163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic control in pregnant diabetic women using a continuous subcutaneous insulin infusion pump.
    Cohen AW; Liston RM; Mennuti MT; Gabbe SG
    J Reprod Med; 1982 Oct; 27(10):651-4. PubMed ID: 7175835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes.
    Buysschaert M; Lejeune M; Lambert AE
    Diabete Metab; 1981 Sep; 7(3):189-93. PubMed ID: 7319116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy.
    Rizza RA; Gerich JE; Haymond MW; Westland RE; Hall LD; Clemens AH; Service FJ
    N Engl J Med; 1980 Dec; 303(23):1313-8. PubMed ID: 7001229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of unstable diabetes with a portable insulin-infusion pump (author's transl)].
    Talaulicar M; Willms B
    Dtsch Med Wochenschr; 1982 Mar; 107(11):419-23. PubMed ID: 7037348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetes therapy with continuous insulin infusion by a portable pump: metabolic effects of short-term treatment and long-term results in problem patients].
    Schernthaner G; Graninger W; Kwasny W; Prager R; Otto C
    Acta Med Austriaca; 1982; 9(5-6):205-13. PubMed ID: 6762034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience in human diabetics with portable and implantable insulin minipumps.
    Mirouze J; Selam JL; Slingeneyer A; Chaptal PA; Hedon B; Mares P; Franetzki M; Prestele K; Millet P; Beraud JJ
    Life Support Syst; 1983; 1(1):39-49. PubMed ID: 6678370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of unstable diabetes by continuous subcutaneous infusion of insulin].
    Capani F; Consoli A; Guagnano T; Vitacolonna E; Sensi S
    Boll Soc Ital Biol Sper; 1981 Jul; 57(13):1424-6. PubMed ID: 7284110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections.
    Meneghini L; Sparrow-Bodenmiller J
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S109-14. PubMed ID: 20515298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ambulatory treatment of diabetes in children by continuous subcutaneous infusion of insulin using a portable pump].
    Bougnères PF; Landier F; Lemmel C; Golse B; Chaussain JL
    Arch Fr Pediatr; 1984 Jan; 41(1):27-33. PubMed ID: 6721650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of porcine insulin and human insulin (Novo) using the glucose-controlled insulin infusion system, glucose-insulin dose-response curves, and the outpatient effectiveness of human insulin (Novo) in insulin-dependent diabetes.
    Charles MA; Szekeres A; Staten M; Worcester B; Walsh KM
    Diabetes Care; 1983; 6 Suppl 1():29-34. PubMed ID: 6343034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study.
    Berhe T; Postellon D; Wilson B; Stone R
    Pediatrics; 2006 Jun; 117(6):2132-7. PubMed ID: 16740857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.
    Nimri R; Weintrob N; Benzaquen H; Ofan R; Fayman G; Phillip M
    Pediatrics; 2006 Jun; 117(6):2126-31. PubMed ID: 16740856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of ambulatory unstable diabetic patients by continuous subcutaneous infusion of insulin: preliminary results (author's transl)].
    Lambert AE; Buysschaert M; Van Halle B
    Diabete Metab; 1979 Dec; 5(4):307-12. PubMed ID: 398299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous intravenous insulin therapy with a miniaturized open-loop system.
    Renner R; Hepp KD; Mehnert H; Franetzki M
    Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
    Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
    Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin pump therapy (continuous subcutaneous insulin infusion).
    White RD
    Prim Care; 2007 Dec; 34(4):845-71, vii. PubMed ID: 18061820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.